Category: Cbd Products

  • Can CBD Help With Meth, Cocaine Addiction?

    Can CBD Help With Meth, Cocaine Addiction?

    Researchers examined whether CBD has the potential to treat meth and cocaine addiction.

    CBD could help treat methamphetamine and cocaine addictions, for which there are currently no medication-assisted treatment options, according to a study released earlier this month. 

    The study, published in the journal Molecules, found that CBD helped reduce cocaine and methamphetamine use in rodents, and lowered their risk of relapse after a period of sobriety. The study authors say that the findings indicate that CBD should be explored as a treatment option for humans. 

    “While preliminary, there is some preclinical evidence showing that treatment with CBD might promote resilience to developing cocaine and meth use disorders and might prevent relapse into drug use after a period of abstinence,” the study authors wrote, according to Marijuana Moment.  

    Other Studies

    Studies have shown that mice that are given higher doses of CBD are less likely to continue seeking out cocaine or methamphetamine. After 14 days without meth or cocaine, mice that were given CBD over an extended time period were less likely to relapse. 

    “A limited number of preclinical studies indicate that CBD could have therapeutic properties on cocaine and meth addiction and some preliminary data suggest that CBD may be beneficial in cocaine-crack addiction in humans,” the study authors wrote. “CBD has shown promising results in reducing the inflammation and seizures induced by cocaine and in several preclinical models of addiction to amphetamine, cocaine and meth. Importantly, a brief treatment of CBD induces a long-lasting prevention of reinstatement of cocaine and meth-seeking behaviors.”

    While medication-assisted treatment for opioid use disorder has become the standard of care, there is currently no option for treating cocaine or meth addiction with medication. 

    “We’re realizing that we don’t have everything we might wish we had to address these different kinds of drugs,” psychiatrist Margaret Jarvis, a distinguished fellow of the American Society of Addiction Medicine, said earlier this year

    This isn’t the first time a study has indicated that CBD has potential for treating addiction. Last year a study also found that rats who received CBD were less likely to administer cocaine or alcohol, even when they were cued to take the substances. 

    Researcher Yasmin Hurd, director of the Addiction Institute at Mount Sinai School of Medicine in New York, has studied the potential of CBD for treating addiction. 

    “When we started investigating CBD, we hypothesized that perhaps it could decrease drug-taking behavior, but instead we saw that it actually decreased craving,” she said last year. “It was very specific about what it decreased, and that was surprising. Other researchers have replicated what we found, so we are confident in our results.”

    View the original article at thefix.com

  • FDA Issues Consumer Warning On CBD Products

    FDA Issues Consumer Warning On CBD Products

    The FDA is working to research the safety of CBD and other cannabis products to better understand how to regulate them.

    The Food and Drug Administration has issued a consumer warning urging people to proceed with caution when using CBD products for themselves or their animals. 

    “The U.S. Food and Drug Administration (FDA) recognizes the significant public interest in cannabis and cannabis-derived compounds, particularly CBD,” the warning reads. “However, there are many unanswered questions about the science, safety, and quality of products containing CBD.”

    The FDA has only approved one CBD product, the anti-seizure medication Epidiolex. Despite that, many other products make health claims as they relate to people and animals, but the FDA cautions consumers that these claims are unsubstantiated. 

    More Research Is Needed

    “The FDA has not approved any other CBD products, and there is very limited available information about CBD, including about its effects on the body,” the warning said. 

    The FDA is working to research the safety of CBD and other cannabis products to better understand how to regulate them. This includes looking at the way that CBD affects the liver. Research has indicated that CBD can be linked with liver damage, which is cause for concern as people use the product liberally. 

    More importantly, the FDA points out that people should not use CBD products as a replacement for medical care. 

    “Misleading and false claims associated with CBD products may lead consumers to put off getting important medical care, such as proper diagnosis, treatment, and supportive care,” the warning read. “For that reason, it’s important to talk to your doctor about the best way to treat diseases or conditions with existing, approved treatment options.”

    Protecting Public Health

    The agency has issued warnings to companies that market their CBD products as ways to relieve the effects of certain diseases. 

    “The FDA’s top priority is to protect the public health, and that includes making sure consumers know about products that put their health and safety at greatest risk, such as those claiming to prevent, diagnose, treat, or cure serious diseases,” the organization wrote. 

    In addition to better understanding how CBD affects people, the FDA is researching how CBD affects animals, and whether it is safe for animal use. Right now there are many CBD products marketing for animals, but the claims for their effects are unproven, the organization said. 

    The organization is collecting public comments online through July 16. The public input will help inform policy going forward. 

    “The FDA continues to believe the drug approval process represents the best way to help ensure that safe and effective new medicines, including any drugs derived from cannabis, are available to patients in need of appropriate medical therapy,” the organization wrote. “The Agency is committed to supporting the development of new drugs, including cannabis and cannabis-derived drugs, through the investigational new drug and drug approval process.”

    View the original article at thefix.com